A novel cell type negatively associated with secondary autoimmunity in alemtuzumab-treated patients is revealed through single-cell longitudinal analysis of clinical trial samplesVirginia Savova, Emanuele de Rinaldis, Frank O. Nestlé et al.|Research Square|2021Cited by 0
A novel cell type negatively associated with secondary autoimmunity in alemtuzumab-treated patients is revealed through single-cell longitudinal analysis of clinical trial samplesRicha Hanamsagar, Virginia Savova, K. Klinger et al.|medRxiv|2021Cited by 0
A novel cell type negatively associated with secondary autoimmunity in alemtuzumab-treated patients is revealed through single-cell longitudinal analysis of clinical trial samplesVirginia Savova, Emanuele de Rinaldis, Richa Hanamsagar et al.|Research Square|2021Cited by 0